Jupiter Asset Management LTD Acadia Pharmaceuticals Inc Transaction History

Jupiter Asset Management LTD

$11 Billion
Q3 2024

A detailed history of Jupiter Asset Management LTD transactions in Acadia Pharmaceuticals Inc stock. As of the latest transaction made, Jupiter Asset Management LTD holds 157,457 shares of ACAD stock, worth $2.56 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

157,457

Previous 1,060,840 85.16%

Holding current value

$2.56 Million

Previous $17.2 Million 85.94%

% of portfolio

0.02%

Previous 0.17%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	SELL	$15.14 - $19.14 $13.7 Million - $17.3 Million	-903,383 Reduced 85.16%	157,457 $2.42 Million
Q2 2024 Aug 08, 2024	SELL	$14.62 - $18.42 $7.94 Million - $10 Million	-542,934 Reduced 33.85%	1,060,840 $17.2 Million
Q1 2024 May 10, 2024	BUY	$17.79 - $30.86 $5.01 Million - $8.68 Million	281,410 Added 21.28%	1,603,774 $29.7 Million
Q4 2023 Feb 09, 2024	BUY	$20.78 - $31.77 $958,955 - $1.47 Million	46,148 Added 3.62%	1,322,364 $41.4 Million
Q3 2023 Nov 09, 2023	BUY	$20.84 - $33.47 $102,782 - $165,074	4,932 Added 0.39%	1,276,216 $26.6 Million
Q2 2023 Aug 10, 2023	SELL	$17.8 - $25.65 $1.71 Million - $2.47 Million	-96,317 Reduced 7.04%	1,271,284 $30.4 Million
Q1 2023 May 10, 2023	BUY	$16.32 - $20.92 $4.53 Million - $5.81 Million	277,629 Added 25.47%	1,367,601 $25.7 Million
Q4 2022 Feb 10, 2023	BUY	$14.2 - $18.63 $14.4 Million - $18.9 Million	1,012,680 Added 1310.2%	1,089,972 $17.4 Million
Q3 2022 Nov 10, 2022	BUY	$14.11 - $18.27 $173,172 - $224,227	12,273 Added 18.88%	77,292 $1.27 Million
Q2 2022 Aug 10, 2022	BUY	$13.01 - $27.22 $845,897 - $1.77 Million	65,019 New	65,019 $917,000
Q4 2020 Feb 10, 2021	SELL	$41.04 - $56.79 $4.77 Million - $6.6 Million	-116,258 Closed	0 $0
Q3 2020 Nov 10, 2020	BUY	$36.42 - $57.0 $4.23 Million - $6.63 Million	116,258 New	116,258 $4.8 Million

Others Institutions Holding ACAD

# of Institutions

280

Shares Held

156M

Call Options Held

901K

Put Options Held

314K

View Full List

About ACADIA PHARMACEUTICALS INC

Ticker ACAD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 161,843,008
Market Cap $2.63B
Description
ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's p...

More about ACAD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Jupiter Asset Management LTD, based on Form 13F filings with the SEC.

News

Stay updated on Jupiter Asset Management LTD with notifications on news.

Account

Jupiter Asset Management LTD Acadia Pharmaceuticals Inc Transaction History